The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activating genomic mutations in the mTOR pathway to predict responses to everolimus and temsirolimus in patients with metastatic renal cell carcinoma (mRCC): Results from a large multi-institutional cohort.
 
Andre Poisl Fay
No Relationships to Disclose
 
David J. Kwiatkowski
Consulting or Advisory Role - Novartis
 
Kathryn P. Gray
Stock and Other Ownership Interests - DYAX
 
Aaron Thorner
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Millennium (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - Exelixis; Medivation; Takeda
 
Thai Huu Ho
No Relationships to Disclose
 
Jiaxi Song
No Relationships to Disclose
 
Pablo M Barrios
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Novartis; Pfizer; Sanofi
Research Funding - novartis (Inst); pfizer (Inst)
 
Eliezer Mendel Van Allen
Consulting or Advisory Role - Roche; Syapse
 
Katherine Maragaret Krajewski
No Relationships to Disclose
 
Camillo Porta
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Pfizer; Pierre Fabre
Research Funding - Novartis; Pfizer
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Sabina Signoretti
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer